NF-κB inhibition not only decreased the motility and invasiveness of MDA-MB-231 and HCC-1954 cells (Figs 1 and 2) but also reduced the expression of EMT markers in a significant manner (Figs 3 and 4). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.